"The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved t"...
MUTAMYCIN (mitomycin) is contraindicated in patients who have demonstrated a hypersensitive or idiosyncratic reaction to it in the past.
MUTAMYCIN (mitomycin) is contraindicated in patients with thrombocytopenia, coagulation disorder, or an increase in bleeding tendency due to other causes.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/24/2008
Additional Mutamycin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.